OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 40 filers reported holding OVID THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $224,000 | -2.2% | 71,489 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $229,000 | -39.1% | 71,489 | -36.2% | 0.01% | -50.0% |
| Q3 2021 | $376,000 | -32.0% | 112,044 | -20.8% | 0.01% | -44.4% |
| Q2 2021 | $553,000 | +4.3% | 141,433 | +7.3% | 0.02% | -10.0% |
| Q1 2021 | $530,000 | +204.6% | 131,834 | +125.9% | 0.02% | +42.9% |
| Q1 2020 | $174,000 | -44.6% | 58,368 | -22.9% | 0.01% | -48.1% |
| Q4 2019 | $314,000 | +22.2% | 75,738 | -4.6% | 0.03% | +12.5% |
| Q3 2019 | $257,000 | – | 79,395 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,252,892 | $10,930,000 | 4.97% |
| GLOBEFLEX CAPITAL L P | 1,397,770 | $4,697,000 | 1.02% |
| BVF INC/IL | 6,631,051 | $22,280,000 | 0.87% |
| EcoR1 Capital, LLC | 6,082,200 | $20,436,000 | 0.71% |
| Ikarian Capital, LLC | 1,105,082 | $3,715,000 | 0.26% |
| CHI Advisors LLC | 233,510 | $785,000 | 0.23% |
| DCF Advisers, LLC | 141,701 | $476,000 | 0.21% |
| Artal Group S.A. | 2,500,000 | $8,400,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,577,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 1,903,162 | $6,394,000 | 0.02% |